🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1997-04
Trial ID
NCT00019214
Treatments Being Tested
RATIONALE: Vaccines made from melanoma cells may make the body build an imm...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
1999-06
Trial ID
NCT00006113
RATIONALE: Vaccines made from a person's white blood cells combined with me...
Status
Unknown
Location
Dana-Farber Cancer Institute
Start Date
1999-03
Trial ID
NCT00004025
Treatments Being Tested
RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
2003-10
Trial ID
NCT00334776
RATIONALE: Vaccines made from gene-modified tumor cells may help the body b...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2008-11
Trial ID
NCT00798629
Treatments Being Tested
Randomized phase I trial to study the effectiveness of vaccine therapy in t...
Status
Completed
Location
University of Pennsylvania Cancer Center
Start Date
1999-04
Trial ID
NCT00003665
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00019890
Treatments Being Tested
RATIONALE: Vaccines made from a person's white blood cells and melanoma cel...
Status
Completed
Location
Baylor University Medical Center
Start Date
1999-04
Trial ID
NCT00003792
RATIONALE: Vaccines made from dendritic cells and tumor antigen peptides or...
Status
Unknown
Location
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology - Warsaw
Start Date
2002-10
Trial ID
NCT01082198
Treatments Being Tested